Pure Global

Exploratory prospective clinical study on predictors of efficacy of immune checkpoint inhibitors and immune-related adverse events in early-stage breast cancer - Trial UMIN000050985

Access comprehensive clinical trial information for UMIN000050985 through Pure Global AI's free database. This Not Applicable trial is sponsored by Showa university and is currently Recruiting. The study focuses on Breast cancer.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000050985
Not Applicable
Recruiting
Trial Details
University Hospital Medical Information Network โ€ข UMIN000050985
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Exploratory prospective clinical study on predictors of efficacy of immune checkpoint inhibitors and immune-related adverse events in early-stage breast cancer

Study Focus

Breast cancer

Observational

Sponsor & Location

Showa university

Japan

Timeline & Enrollment

Not Applicable

Apr 25, 2023

N/A

ICD-10 Classifications

Malignant neoplasm of breast
Malignant neoplasm of breast
Carcinoma in situ of breast, unspecified
Malignant neoplasm: Breast, unspecified
Other carcinoma in situ of breast

Data Source

University Hospital Medical Information Network

UMIN000050985

Non-Device Trial